These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25926247)

  • 1. Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways.
    Sousa V; Bastos B; Silva M; Alarcão AM; Carvalho L
    Rev Port Pneumol (2006); 2015; 21(5):259-70. PubMed ID: 25926247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status.
    Sousa V; Rodrigues C; Silva M; Alarcão AM; Carvalho L
    Rev Port Pneumol (2006); 2015; 21(3):113-25. PubMed ID: 25926253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.
    Chantranuwat C; Sriuranpong V; Huapai N; Chalermchai T; Leungtaweeboon K; Voravud N; Mutirangura A
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S322-9. PubMed ID: 16623049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
    Hwang I; Park KU; Kwon KY
    Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
    Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
    Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EGFR and molecules downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) pathways in invasive lung adenocarcinomas resected at a single institution.
    Torres AF; Nogueira C; Magalhaes J; Costa IS; Aragao A; Gomes Neto A; Martins F; Tavora F
    Anal Cell Pathol (Amst); 2014; 2014():352925. PubMed ID: 25763322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications.
    Kim J; Jang SJ; Choi CM; Ro JY
    Adv Anat Pathol; 2016 Sep; 23(5):330-8. PubMed ID: 27403614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Chen Z; Liu X; Zhao J; Yang H; Teng X
    Int J Clin Exp Pathol; 2014; 7(11):8039-45. PubMed ID: 25550848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
    Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
    Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
    World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of different patterns of pulmonary adenocarcinomas.
    Truini A; Santos Pereira P; Cavazza A; Spagnolo P; Nosseir S; Longo L; Jukna A; Lococo F; Vincenzi G; Bogina G; Tiseo M; Rossi G
    Expert Rev Respir Med; 2015 Oct; 9(5):571-86. PubMed ID: 26313326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma.
    Takuwa T; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Neri S; Hasegawa S; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3943-52. PubMed ID: 22669454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reclassifying bronchial-pulmonary carcinoma: differentiating histological type in biopsies by immunohistochemistry.
    Carvalho L
    Rev Port Pneumol; 2009; 15(6):1101-19. PubMed ID: 19859629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the microvessel density and the expression of metalloproteases 2 and 9 and ttf1 in the different subtypes of lung adenocarcinoma in Tunisia: a retrospective study of 46 cases.
    Mlika M; Makhlouf C; Boudaya MS; Haddouchi C; Tritar F; Mezni F
    J Immunoassay Immunochem; 2015; 36(2):111-8. PubMed ID: 24689794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.
    Warth A; Stenzinger A; von Brünneck AC; Goeppert B; Cortis J; Petersen I; Hoffmann H; Schnabel PA; Weichert W
    Eur Respir J; 2012 Nov; 40(5):1221-7. PubMed ID: 22408209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.
    Sánchez-Mora N; Presmanes MC; Monroy V; Moreno N; Lara-Martínez JM; Aladro MH; Alvarez-Fernández E
    Hum Pathol; 2008 Mar; 39(3):324-30. PubMed ID: 18261622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.
    Zabeck H; Dienemann H; Hoffmann H; Pfannschmidt J; Warth A; Schnabel PA; Muley T; Meister M; Sültmann H; Fröhlich H; Kuner R; Lasitschka F
    PLoS One; 2018; 13(10):e0206132. PubMed ID: 30352093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
    Tomonaga N; Nakamura Y; Yamaguchi H; Ikeda T; Mizoguchi K; Motoshima K; Doi S; Nakatomi K; Iida T; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2013 Sep; 14(5):521-6. PubMed ID: 23786997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.
    De Oliveira Duarte Achcar R; Nikiforova MN; Yousem SA
    Am J Clin Pathol; 2009 May; 131(5):694-700. PubMed ID: 19369630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.